Promise Bio Company
Promise Bio is focused on pioneering precision medicine by utilizing epiproteomic analysis to understand autoimmune diseases. The company employs a cloud-based AI platform to perform comprehensive analyses of standard mass-spectrometry data, revealing insights into protein modifications that affect disease mechanisms.
Technology:
AI-driven Drug Target Identification
Founded Date:
2023-01-01 00:00:00
Industry:
BioPharma AI
Funding Status:
private
Headquarters:
Tel Aviv,Tel Aviv,Israel,Asia